New stent graft offers hope for aortic tear patients
NCT ID NCT02380716
First seen Jun 25, 2026 · Last updated Jun 25, 2026
Summary
This study tested a new device called the GORE® Ascending Stent Graft to treat a serious tear in the main artery from the heart (aortic dissection). Twenty-one people with a specific type of tear received the stent graft through a small incision. The main goal was to see if the procedure was safe and could seal the tear. Results will help doctors understand if this less invasive option could work for more patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC DISSECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Southern California- Keck Medicine
Los Angeles, California, 90033, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE® Ascending Stent Graft (a device placed inside the aorta to repair the tear)
What this could lead to
If successful, this device could offer a less invasive way to treat a life-threatening tear in the main artery, potentially reducing the need for open-heart surgery.
What could go wrong
This was a small, early feasibility study with only 21 participants. The device may not work for everyone, and there are risks like bleeding, infection, or the stent not sealing properly.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.